Why the study?
Do concurrent measurements of B-type natriuretic peptides and LVEF improve prognostic risk stratification for death, heart failure, and new myocardial infarction in patients with acute myocardial infarction?
Population
666 patients with acute myocardial infarction
Design
Cohort
Follow-up
3 years
Authors
Loading...
May refine post-MI risk stratification via combined LVEF and N-BNP; hypothesis-generating for prospective trials.
Do concurrent measurements of B-type natriuretic peptides and LVEF improve prognostic risk stratification for death, heart failure, and new myocardial infarction in patients with acute myocardial infarction?
Combined measurement of N-BNP (or BNP) and LVEF provides substantially better risk stratification for major adverse events after myocardial infarction than either marker alone.
Richards et al. (2003) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: